Fidson established its first local manufacturing facility in July 2002 and later became the first business in sub-Saharan Africa to produce antiretroviral medications
Fidson grew its profit for the year by 518% from a loss of N97.45 million in 2018 to N407.19 million in 2019.
Shareholders of Fidson Healthcare Plc have approved a dividend payment of N300 million for the 2018 financial year.
Fidson Healthcare Plc is one of the leading pharmaceutical manufacturing company in Nigeria.
